|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: CECR5 |
Gene summary for CECR5 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | CECR5 | Gene ID | 27440 |
| Gene name | haloacid dehalogenase like hydrolase domain containing 5 | |
| Gene Alias | CECR5 | |
| Cytomap | 22q11.1 | |
| Gene Type | protein-coding | GO ID | GO:0006629 | UniProtAcc | Q9BXW7 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 27440 | CECR5 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.49e-32 | 5.84e-01 | 0.294 |
| 27440 | CECR5 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.40e-05 | 7.22e-01 | 0.3487 |
| 27440 | CECR5 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 7.08e-25 | 6.23e-01 | 0.281 |
| 27440 | CECR5 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.12e-43 | 7.58e-01 | 0.3859 |
| 27440 | CECR5 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.03e-16 | 4.71e-01 | 0.2585 |
| 27440 | CECR5 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 2.92e-23 | 4.66e-01 | 0.3005 |
| 27440 | CECR5 | P1T-E | Human | Esophagus | ESCC | 4.40e-04 | 2.72e-01 | 0.0875 |
| 27440 | CECR5 | P2T-E | Human | Esophagus | ESCC | 1.07e-31 | 6.58e-01 | 0.1177 |
| 27440 | CECR5 | P4T-E | Human | Esophagus | ESCC | 1.43e-50 | 1.30e+00 | 0.1323 |
| 27440 | CECR5 | P5T-E | Human | Esophagus | ESCC | 2.97e-32 | 6.59e-01 | 0.1327 |
| 27440 | CECR5 | P8T-E | Human | Esophagus | ESCC | 1.30e-13 | 2.54e-01 | 0.0889 |
| 27440 | CECR5 | P9T-E | Human | Esophagus | ESCC | 1.01e-20 | 5.58e-01 | 0.1131 |
| 27440 | CECR5 | P10T-E | Human | Esophagus | ESCC | 2.86e-49 | 9.24e-01 | 0.116 |
| 27440 | CECR5 | P11T-E | Human | Esophagus | ESCC | 6.24e-27 | 8.71e-01 | 0.1426 |
| 27440 | CECR5 | P12T-E | Human | Esophagus | ESCC | 1.48e-41 | 9.43e-01 | 0.1122 |
| 27440 | CECR5 | P15T-E | Human | Esophagus | ESCC | 6.62e-48 | 1.00e+00 | 0.1149 |
| 27440 | CECR5 | P16T-E | Human | Esophagus | ESCC | 1.09e-62 | 1.07e+00 | 0.1153 |
| 27440 | CECR5 | P17T-E | Human | Esophagus | ESCC | 2.77e-11 | 6.21e-01 | 0.1278 |
| 27440 | CECR5 | P19T-E | Human | Esophagus | ESCC | 1.08e-05 | 5.39e-01 | 0.1662 |
| 27440 | CECR5 | P20T-E | Human | Esophagus | ESCC | 6.12e-18 | 4.04e-01 | 0.1124 |
| Page: 1 2 3 4 5 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |